Patent details

EP3423042 Title: A LYOPHILISED PHARMACEUTICAL FORMULATION AND ITS USE

Basic Information

Publication number:
EP3423042
PCT Application Number:
FI2017050128
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP177112463
PCT Publication Number:
WO2017149199
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A LYOPHILISED PHARMACEUTICAL FORMULATION AND ITS USE
French Title of Invention:
FORMULATION PHARMACEUTIQUE LYOPHILISÉE ET SON UTILISATION
German Title of Invention:
LYOPHILISIERTE PHARMAZEUTISCHE FORMULIERUNG UND DESSEN VERWENDUNG
SPC Number:

Dates

Filing date:
28/02/2017
Grant date:
27/04/2022
EP Publication Date:
09/01/2019
PCT Publication Date:
08/09/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/04/2022
EP B1 Publication Date:
27/04/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/02/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/04/2022
 
 

Name:
Faron Pharmaceuticals OY
Address:
Joukahaisenkatu 6, 20520 Turku, Finland (FI)

Inventor

1

Name:
PIIPPO, Ilse
Address:
Finland (FI)

2

Name:
JALKANEN, Markku
Address:
Finland (FI)

3

Name:
MAKSIMOW, Mikael
Address:
Finland (FI)

Priority

Priority Number:
20165153
Priority Date:
29/02/2016
Priority Country:
Finland (FI)

Classification

IPC classification:
A61K 9/19; A61K 38/21; A61P 1/18; A61P 9/00; A61P 13/12; A61P 29/00;

Publication

European Patent Bulletin

Issue number:
202217
Publication date:
27/04/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/03/2027
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/02/2026
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL (PATRAFEE) AB
Filing date Document type Number of pages